BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 23513830)

  • 21. [The role of integrin in the invasion and metastasis of gastric cancer].
    Matsuura N; Fujiwara A; Mori S; Yamaguchi M
    Nihon Rinsho; 2001 Apr; 59 Suppl 4():94-100. PubMed ID: 11424460
    [No Abstract]   [Full Text] [Related]  

  • 22. Tumor cell adhesive mechanisms and their relationship to metastasis.
    McCarthy JB; Skubitz AP; Iida J; Mooradian DL; Wilke MS; Furcht LT
    Semin Cancer Biol; 1991 Jun; 2(3):155-67. PubMed ID: 1912525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Matrix metalloproteinases and cancer cell invasion and metastasis].
    Imai K
    Tanpakushitsu Kakusan Koso; 1997 Jul; 42(10 Suppl):1694-700. PubMed ID: 9279101
    [No Abstract]   [Full Text] [Related]  

  • 24. Acidic polysaccharide from Phellinus linteus inhibits melanoma cell metastasis by blocking cell adhesion and invasion.
    Han SB; Lee CW; Kang JS; Yoon YD; Lee KH; Lee K; Park SK; Kim HM
    Int Immunopharmacol; 2006 Apr; 6(4):697-702. PubMed ID: 16504934
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NK4, a four-kringle antagonist of HGF, inhibits spreading and invasion of human pancreatic cancer cells.
    Maehara N; Matsumoto K; Kuba K; Mizumoto K; Tanaka M; Nakamura T
    Br J Cancer; 2001 Mar; 84(6):864-73. PubMed ID: 11259105
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Roles of CUB domain-containing protein 1 signaling in cancer invasion and metastasis.
    Uekita T; Sakai R
    Cancer Sci; 2011 Nov; 102(11):1943-8. PubMed ID: 21812858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suppression of metastatic potential of high-metastatic Lewis lung carcinoma cells by vanadate, an inhibitor of tyrosine phosphatase, through inhibiting cell-substrate adhesion.
    Takenaga K
    Invasion Metastasis; 1996; 16(2):97-106. PubMed ID: 9030244
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biologic factors required in cancer invasion and metastasis.
    Abecassis J; Million R; Muller D; Eber M; Methlin G
    Prog Clin Biol Res; 1990; 348():23-33. PubMed ID: 1696736
    [No Abstract]   [Full Text] [Related]  

  • 29. Molecular insights into cancer invasion: strategies for prevention and intervention.
    Kohn EC; Liotta LA
    Cancer Res; 1995 May; 55(9):1856-62. PubMed ID: 7728753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Colorectal carcinoma--current pathogenetic concepts. Significance of cell-matrix interaction for invasive growth and metastasis].
    Stallmach A; Riecken EO
    Schweiz Rundsch Med Prax; 1992 Jun; 81(26):847-9. PubMed ID: 1626158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Metalloproteinases in tumor progression. Review].
    Arvelo F; Cotte C
    Invest Clin; 2006 Jun; 47(2):185-205. PubMed ID: 16886780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New Trends in the Therapy of Tumor Dissemination - Clinical and Experimental Aspects. Symposium. Budapest, Hungary, 1-3 April 1993. Abstracts.
    Anticancer Res; 1993; 13(6B):2587-600. PubMed ID: 7907852
    [No Abstract]   [Full Text] [Related]  

  • 33. The role of engineering approaches in analysing cancer invasion and metastasis.
    Zaman MH
    Nat Rev Cancer; 2013 Aug; 13(8):596-603. PubMed ID: 23864050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Shifting paradigms in tumor metastasis: challenges and opportunities.
    Parsons JT; Zetter B; Mohla S
    Cancer Biol Ther; 2002; 1(5):582-5. PubMed ID: 12496493
    [No Abstract]   [Full Text] [Related]  

  • 35. The potential for proteinase inhibition in cancer treatment.
    Dodwell DJ; Howell A
    Cancer Treat Rev; 1993 Jul; 19(3):283-96. PubMed ID: 8334678
    [No Abstract]   [Full Text] [Related]  

  • 36. Antiangiogenic agents.
    Di Donna A
    Curr Pharm Des; 2010; 16(35):3862-3. PubMed ID: 21171950
    [No Abstract]   [Full Text] [Related]  

  • 37. [Prevention of tumour invasion].
    Hoshino D; Koshikawa N; Seiki M; Taniguchi H
    Nihon Rinsho; 2012 Nov; 70 Suppl 8():154-8. PubMed ID: 23513830
    [No Abstract]   [Full Text] [Related]  

  • 38. The insulin-like growth factor-I receptor inhibitor picropodophyllin causes tumor regression and attenuates mechanisms involved in invasion of uveal melanoma cells.
    Girnita A; All-Ericsson C; Economou MA; Aström K; Axelson M; Seregard S; Larsson O; Girnita L
    Acta Ophthalmol; 2008 Nov; 86 Thesis 4():26-34. PubMed ID: 19032679
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumour invasion and metastasis: challenges facing drug discovery.
    Elvin P; Garner AP
    Curr Opin Pharmacol; 2005 Aug; 5(4):374-81. PubMed ID: 15955738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduction of metastasis, cell invasion, and adhesion in mouse osteosarcoma by YM529/ONO-5920-induced blockade of the Ras/MEK/ERK and Ras/PI3K/Akt pathway.
    Tsubaki M; Satou T; Itoh T; Imano M; Ogaki M; Yanae M; Nishida S
    Toxicol Appl Pharmacol; 2012 Mar; 259(3):402-10. PubMed ID: 22326785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.